News

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
If you're among the half of US adults who have tried to lose weight in the last 12 months, you'll be aware of how enthusiasm ...
But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
Gemma Collins's shrinking frame has left her with an unwelcome side effect - but the Diva Forever star is determined to take swift action in her quest for 'perfection', a source says ...
Weight loss is often clouded by misinformation and popular myths. Believing these false ideas can hinder progress, lead to ...
It wasn’t until she received expert advice that she began seeing real results. “I’ve struggled for years with maintaining my ...